| - GRCh37:
- ChrMT:5782-13922
- GRCh38:
- ChrMT:5782-13922
| MT-ND4L, MT-ND5, MT-TC, MT-TD, MT-TR, MT-TS1, MT-TK, MT-TL2, MT-TS2, MT-TH, MT-TY, MT-ND4, MT-TG, MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-ND3 | | Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemia | Likely pathogenic (Nov 4, 2014) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5794-14876
- GRCh38:
- ChrMT:5794-14876
| MT-CYB, MT-ND3, MT-TL2, MT-TR, MT-TS1, MT-TS2, MT-TY, MT-ATP6, MT-ATP8, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-ND6, MT-TC, MT-TD, MT-CO1, MT-CO2, MT-CO3, MT-TE, MT-TK | | Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemia | Likely pathogenic (Nov 4, 2014) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:6003-11220
- GRCh38:
- ChrMT:6003-11220
| MT-TR, MT-TS1, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-TD, MT-TG, MT-TK, MT-ATP6, MT-ATP8, MT-CO1, MT-CO2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:6468-15586
- GRCh38:
- ChrMT:6468-15586
| MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-TD, MT-TE, MT-TG, MT-TH, MT-TK, MT-TL2, MT-TR, MT-TS1, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:7126-13988
- GRCh38:
- ChrMT:7126-13988
| MT-CO1, MT-CO2, MT-CO3, MT-ND3, MT-TD, MT-TG, MT-TL2, MT-TR, MT-TS1, MT-TS2, MT-ND4, MT-ND4L, MT-ND5, MT-TH, MT-TK, MT-ATP6, MT-ATP8 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:7730-11255
- GRCh38:
- ChrMT:7730-11255
| MT-CO3, MT-ND3, MT-ATP6, MT-ATP8, MT-CO2, MT-ND4, MT-ND4L, MT-TG, MT-TK, MT-TR | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8290-13040
- GRCh38:
- ChrMT:8290-13040
| MT-TR, MT-TS2, MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TK, MT-TL2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8350-13450
- GRCh38:
- ChrMT:8350-13450
| MT-TR, MT-TS2, MT-TK, MT-TL2, MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH | | Pearson syndrome | Pathogenic (Jun 12, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8470-13446
- GRCh38:
- ChrMT:8470-13446
| MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2, MT-CO3, MT-ND3, MT-ND4, MT-ATP6, MT-ATP8, MT-ND4L, MT-ND5 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8480-13440
- GRCh38:
- ChrMT:8480-13440
| MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TR, MT-TS2, MT-TG, MT-TH, MT-TL2 | | Pearson syndrome | Pathogenic (Jun 12, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8585-12965
- GRCh38:
- ChrMT:8585-12965
| MT-ATP6, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8815-13722
- GRCh38:
- ChrMT:8815-13722
| MT-ATP6, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8839-14895
- GRCh38:
- ChrMT:8839-14895
| MT-ATP6, MT-CO3, MT-CYB, MT-ND5, MT-ND6, MT-TE, MT-TG, MT-TS2, MT-ND3, MT-ND4, MT-ND4L, MT-TH, MT-TL2, MT-TR | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:10105-15066
- GRCh38:
- ChrMT:10105-15066
| MT-CYB, MT-ND3, MT-ND4, MT-TH, MT-TL2, MT-TR, MT-TS2, MT-ND4L, MT-ND5, MT-ND6, MT-TE | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:10775
- GRCh38:
- ChrMT:10775
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10776
- GRCh38:
- ChrMT:10776
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10785
- GRCh38:
- ChrMT:10785
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10791
- GRCh38:
- ChrMT:10791
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10798
- GRCh38:
- ChrMT:10798
| MT-ND4 | | not provided | Likely benign (Mar 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10845
- GRCh38:
- ChrMT:10845
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10857
- GRCh38:
- ChrMT:10857
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10863
- GRCh38:
- ChrMT:10863
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10887
- GRCh38:
- ChrMT:10887
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10895
- GRCh38:
- ChrMT:10895
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10899
- GRCh38:
- ChrMT:10899
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10907
- GRCh38:
- ChrMT:10907
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10911
- GRCh38:
- ChrMT:10911
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10913
- GRCh38:
- ChrMT:10913
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10914
- GRCh38:
- ChrMT:10914
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10915
- GRCh38:
- ChrMT:10915
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10920
- GRCh38:
- ChrMT:10920
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10922
- GRCh38:
- ChrMT:10922
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10931
- GRCh38:
- ChrMT:10931
| MT-ND4 | | not provided, Leigh syndrome | Conflicting interpretations of pathogenicity (Oct 17, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:10932
- GRCh38:
- ChrMT:10932
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:10947-15537
- GRCh38:
- ChrMT:10947-15537
| MT-TL2, MT-TS2, MT-CYB, MT-ND4, MT-ND5, MT-ND6, MT-TE, MT-TH | | Pearson syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11004
- GRCh38:
- ChrMT:11004
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11013
- GRCh38:
- ChrMT:11013
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11016
- GRCh38:
- ChrMT:11016
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11016
- GRCh38:
- ChrMT:11016
| MT-ND4 | | not provided | Uncertain significance (Jun 26, 2017) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11025
- GRCh38:
- ChrMT:11025
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11032
- GRCh38:
- ChrMT:11032
| MT-ND4 | | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:11039
- GRCh38:
- ChrMT:11039
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11043
- GRCh38:
- ChrMT:11043
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11061
- GRCh38:
- ChrMT:11061
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11069
- GRCh38:
- ChrMT:11069
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11084
- GRCh38:
- ChrMT:11084
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11087
- GRCh38:
- ChrMT:11087
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11090
- GRCh38:
- ChrMT:11090
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11111
- GRCh38:
- ChrMT:11111
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11120
- GRCh38:
- ChrMT:11120
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11129
- GRCh38:
- ChrMT:11129
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11139
- GRCh38:
- ChrMT:11139
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11144
- GRCh38:
- ChrMT:11144
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11150
- GRCh38:
- ChrMT:11150
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11151
- GRCh38:
- ChrMT:11151
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11157
- GRCh38:
- ChrMT:11157
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11167
- GRCh38:
- ChrMT:11167
| MT-ND4 | | not provided | Likely benign (Sep 25, 2015) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11172
- GRCh38:
- ChrMT:11172
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11177
- GRCh38:
- ChrMT:11177
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11204
- GRCh38:
- ChrMT:11204
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11223
- GRCh38:
- ChrMT:11223
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11232
- GRCh38:
- ChrMT:11232
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11246
- GRCh38:
- ChrMT:11246
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11252
- GRCh38:
- ChrMT:11252
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11253
- GRCh38:
- ChrMT:11253
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11255
- GRCh38:
- ChrMT:11255
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11263-15374
- GRCh38:
- ChrMT:11263-15374
| MT-ND6, MT-TE, MT-TH, MT-CYB, MT-ND4, MT-ND5, MT-TL2, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:11268
- GRCh38:
- ChrMT:11268
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11289
- GRCh38:
- ChrMT:11289
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11301
- GRCh38:
- ChrMT:11301
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11318
- GRCh38:
- ChrMT:11318
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11337
- GRCh38:
- ChrMT:11337
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11360
- GRCh38:
- ChrMT:11360
| MT-ND4 | | Leber optic atrophy, Leigh syndrome, Seizure
| Uncertain significance (Oct 17, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:11361
- GRCh38:
- ChrMT:11361
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11363
- GRCh38:
- ChrMT:11363
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11393
- GRCh38:
- ChrMT:11393
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11428
- GRCh38:
- ChrMT:11428
| MT-ND4 | | not provided | Likely benign (Sep 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11443
- GRCh38:
- ChrMT:11443
| MT-ND4 | | Visual impairment, Optic atrophy, Optic neuritis, Central scotoma, Optic neuropathy | Uncertain significance (Jan 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11447
- GRCh38:
- ChrMT:11447
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11453
- GRCh38:
- ChrMT:11453
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11467
- GRCh38:
- ChrMT:11467
| MT-ND4 | | not specified, Mitochondrial disease | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:11498
- GRCh38:
- ChrMT:11498
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11560
- GRCh38:
- ChrMT:11560
| MT-ND4 | | not provided | Likely benign (Oct 9, 2015) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11577
- GRCh38:
- ChrMT:11577
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11582
- GRCh38:
- ChrMT:11582
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11583
- GRCh38:
- ChrMT:11583
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11590
- GRCh38:
- ChrMT:11590
| MT-ND4 | | not provided | Uncertain significance (Jan 2, 2017) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11615
- GRCh38:
- ChrMT:11615
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11620-11621
- GRCh38:
- ChrMT:11620-11621
| MT-ND4 | | Leigh syndrome | Likely pathogenic (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11634
- GRCh38:
- ChrMT:11634
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11654
- GRCh38:
- ChrMT:11654
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11696
- GRCh38:
- ChrMT:11696
| MT-ND4 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11708
- GRCh38:
- ChrMT:11708
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11711
- GRCh38:
- ChrMT:11711
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11733
- GRCh38:
- ChrMT:11733
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11777
- GRCh38:
- ChrMT:11777
| MT-ND4 | | Mitochondrial disease | Likely pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:11778
- GRCh38:
- ChrMT:11778
| MT-ND4 | | Mitochondrial disease | Pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:11781
- GRCh38:
- ChrMT:11781
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11792
- GRCh38:
- ChrMT:11792
| MT-ND4 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11807
- GRCh38:
- ChrMT:11807
| MT-ND4 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |